Creative Edge Nutrition, Inc.: A Letter to its Shareholders from Bill Chaaban

BEVERLY HILLS, CA and LAKESHORE, ON / ACCESSWIRE / September 18, 2015 / Creative Edge Nutrition, Inc. (PINKSHEETS: FITX), a nutritional supplement company focusing on active lifestyles, announces an update letter to its shareholders from Bill Chaaban, CEO of CEN Biotech Inc., a wholly owned subsidiary of Creative Edge Nutrition.

Dear Shareholders,

We remain fully committed to execute the business plan set forth two years ago. My team and I have been, and will remain, focused while continuing to actively pursue any and all legal avenues possible to ensure proper justice for CEN Biotech Inc.

We are very excited about the promise of recently disclosed information that, in our opinion, solidifies our position with Canada in our continued pursuit of our earned and deserved license to grow medical marijuana. On September 1, 2015, the Attorney General for Canada was served with our claim for damages under NAFTA. Once the facts surrounding this case are reviewed, we are confident that with this new factual information, CEN Biotech will prevail. This new and relevant information has been sealed by the court, preventing us from disclosing it publically. Additionally, we continue to pursue our license to grow medical marijuana under the Judicial Review process and our fight with Lakeshore at the OMB with these new facts. Our pre-hearing at the OMB is scheduled for January 5, 2016.

We will continue to work tirelessly on your behalf. It remains our intention to spinoff CEN Biotech to its own company as a better vehicle for focused execution. We hope to have news on our intended spinoff shortly as the audit has recently been completed. As you are aware, with all spinoffs shareholders maintain their ownership position with the parent company but are also given shares in the spinoff company.

I personally know that James Robinson, CEO of Creative Edge Nutrition, and his team are aggressively working on the Giddy Up market launch. I have tasted the product, seen the packaging and been made aware of his initial launch partners. I am very impressed with his execution plan and look forward to seeing the product on store shelves soon. I am convinced that, after the spinoff of CEN Biotech, James Robinson will execute a focused plan and continuously add value to his shareholders.

About CEN Biotech

CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.

About Creative Edge Nutrition, Inc.

Creative Edge Nutrition, Inc., is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements and energy drinks. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities.

Company Disclaimer

As a "penny stock" Company, within the meaning of federal and state securities law, Creative Edge Nutrition, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, Creative Edge Nutrition, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers.

Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission.


CEN Biotech, Inc.

SOURCE: Creative Edge Nutrition, Inc.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.